RECURRENT ESOPHAGEAL CARCINOMA
Clinical trials for RECURRENT ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat esophageal cancer?
Disease control OngoingThis study tested if adding a new drug called cixutumumab to standard chemotherapy (paclitaxel) works better for people with advanced esophageal cancer that has spread. It involved 94 patients whose cancer had worsened after one prior treatment. The goal was to see if the combina…
Matched conditions: RECURRENT ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: RECURRENT ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC